Currently out of the existing stock ratings of Prakhar Agrawal, 57 are a BUY (98.28%), 1 are a HOLD (1.72%).

Prakhar Agrawal

Work Performance Price Targets & Ratings Chart

Analyst Prakhar Agrawal, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 39.4% that have a potential upside of 49.24% achieved within 108 days. Previously, Prakhar Agrawal worked at JONESTRADING.

Prakhar Agrawal’s has documented 109 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GPCR, Structure Therapeutics American Depositary Shares at 07-Jun-2026.

Wall Street Analyst Prakhar Agrawal

Analyst best performing recommendations are on TCRT (ALAUNOS THERAPEUTICS).
The best stock recommendation documented was for TCRT (ALAUNOS THERAPEUTICS) at 7/15/2022. The price target of $450 was fulfilled within 48 days with a profit of $252 (127.27%) receiving and performance score of 26.52.

Average potential price target upside

ARNA Arena Pharmaceuticals LABP Landos Biopharma PHAT Phathom Pharmaceuticals OCUP Ocuphire Pharma EQ Equillium MLTX MoonLake Immunotherapeutics TGTX TG Therapeutics NEXI Neximmune PRVB Provention Bio DICE Dice Molecules Holdings LLC AKRO Akero Therapeutics CBAY Cymabay Therapeu RAPT RAPT Therapeutics KROS Keros Therapeutics MDGL Madrigal Pharmaceuticals ORIC Oric Pharmaceuticals GPCR Structure Therapeutics American Depositary Shares TVTX Travere Therapeutics ACRS Aclaris Therapeutics FMTX Forma Therapeutics Holdings TCRT Alaunos Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Dec-2018

$100

$0.01 (0.01%)

$120

4 years 8 months 5 days ago
(09-Feb-2022)

2/5 (40%)

$6.56 (7.02%)

117

Hold Since 27-Dec-2021

$100

$0.01 (0.01%)

$100

4 years 9 months 17 days ago
(27-Dec-2021)

4/7 (57.14%)

$7.96 (8.65%)

204

Buy Since 11-Jul-2017

$79

4 years 9 months 29 days ago
(15-Dec-2021)

5/5 (100%)

$33.14 (72.26%)

401

Buy Since 18-May-2020

$100

4 years 9 months 29 days ago
(15-Dec-2021)

3/4 (75%)

$8 (8.70%)

55

Buy Since 17-Jan-2018

$100

$0.01 (0.01%)

$112

4 years 9 months 29 days ago
(15-Dec-2021)

5/7 (71.43%)

$7.15 (7.70%)

473

Show more analysts

Please expand the browser size to see the chart

Which stock is Prakhar Agrawal most bullish on?

Potential upside of $75.46 has been obtained for GPCR (STRUCTURE THERAPEUTICS AMERICAN DEPOSITARY SHARES)

What Year was the first public recommendation made by Prakhar Agrawal?

On 2021
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?